PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. IPS Pharma
IP

IPS Pharma

London
Large
Not Provided ↗
Compare peers
Awarded
£233k
Live
2
Buyers
3
12m
—
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts2 / 3
  • Top buyers3
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags1
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — IPS PharmaUpdated 13 Jul 2026

At a glance · for buyers and watchdogs

IPS Pharma has won £233k across 3 public-sector buyers, with 2 live contracts.

Why: top buyer NHS South West - Acutes at 100% · 1 active risk flag · 0 modifications.

Decision signals
1Active red flags
ActiveCompany status
2 of 3Live contracts
100%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

⚑ Self-reported & from notices

Service tags, sectors served and target geographies appear here once a supplier verifies ownership of this profile.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 2 live · 1 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
Unlicensed 'Special' and Imported Unlicensed Medicinal Products
NHS South West - Acutes3360000001 Jun 2021£233k3 yrsClosed
Lotted Term Framework for the management and manufacture of research drugs including over-labelling, storage and distribution to trial sites, and associated trial monitoring services
University of Dundee79824000———Live
NP42824 Unlicensed Imported Medicines
NHS Scotland33600000———Live
Total live value — · mean award £78k

Top buyers · 3 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS South West - Acutes
1 contract
100%
since 2021
2
University of Dundee
1 contract
0%
3
NHS Scotland
1 contract
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
South West1 contract
100%
Scotland2 contracts
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). IPS Pharma highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
GX
GXO
No£4.2bn1
AH
Alcura Healthcare Ltd.
No£18.7m1
I(
Ipsos (Market Research) Ltd
No£6.1m4
BR
BMG RESEARCH LTD
No£3.7m1
PF
People For Research Limited
Yes£3.0m1
IP
IPS Pharma
No——
Compare peers →

Red flags · 1 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
Confirmation statement overdue. Statement was due 12 Feb 2026.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Jan 2026
Confirmation statement
Overdue
Due 12 Feb 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
15454033
Status
Active
Type
Private limited
Incorporated
30 Jan 2024
Reg. office
124-128 City Road, London, EC1V 2NX
SIC codes
46460
Last accounts
31 Jan 2026
Next accounts due
31 Oct 2027

Directors & PSC

  • SLOATA, Florentina — director
    Appointed 30 Jan 2024
  • Mrs Florentina Sloata — person with significant control
    ownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
IPS PHARMA LTD
15454033 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.